Literature DB >> 17208222

Thalidomide destabilizes cyclooxygenase-2 mRNA by inhibiting p38 mitogen-activated protein kinase and cytoplasmic shuttling of HuR.

Soo Hyun Jin1, Tae Il Kim, Kyoung Min Yang, Won Ho Kim.   

Abstract

We investigated the effect of thalidomide on transcriptional and post-transcriptional cyclooxygenase-2 (COX-2) expression, including a pathway leading to COX-2 mRNA destabilization. We found that thalidomide inhibited the interleukin-1beta (IL-1beta)-mediated induction of COX-2 protein and mRNA in Caco-2 cells. Transient transfection with a COX-2 promoter construct demonstrated that thalidomide did not affect IL-1beta-induced transcriptional activation of COX-2, although it did decrease the stability of COX-2 mRNA and suppress IL-1beta-induced cytoplasmic shuttling of an mRNA stabilizing protein, HuR. Thalidomide also suppressed IL-1beta-induced p38 mitogen-activated protein kinase (MAPK) activation, while a p38 MAPK inhibitor destabilized COX-2 mRNA and the cytoplasmic shuttling of HuR induced by IL-1beta. These data suggest that one of the molecular mechanisms of thalidomide may be destabilization of COX-2 mRNA through inhibition of cytoplasmic shuttling of HuR and p38 MAPK.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17208222     DOI: 10.1016/j.ejphar.2006.11.060

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Effect of Inhibiting p38 on HuR Involving in β-AChR Post-transcriptional Mechanisms in Denervated Skeletal Muscle.

Authors:  Hong Wang; Xiao Zhao; Wang Yun; Lian-Hua Chen; Shi-Tong Li
Journal:  Cell Mol Neurobiol       Date:  2019-06-06       Impact factor: 5.046

2.  MSK1 and MSK2 inhibit lipopolysaccharide-induced prostaglandin production via an interleukin-10 feedback loop.

Authors:  Kirsty F MacKenzie; Mirjam W M Van Den Bosch; Shaista Naqvi; Suzanne E Elcombe; Victoria A McGuire; Alastair D Reith; Perry J Blackshear; Jonathan L E Dean; J Simon C Arthur
Journal:  Mol Cell Biol       Date:  2013-02-04       Impact factor: 4.272

3.  Kaposin-B enhances the PROX1 mRNA stability during lymphatic reprogramming of vascular endothelial cells by Kaposi's sarcoma herpes virus.

Authors:  Jaehyuk Yoo; Jinjoo Kang; Ha Neul Lee; Berenice Aguilar; Darren Kafka; Sunju Lee; Inho Choi; Juneyong Lee; Swapnika Ramu; Juergen Haas; Chester J Koh; Young-Kwon Hong
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

Review 4.  Current status of thalidomide and CC-5013 in the treatment of metastatic prostate cancer.

Authors:  Tristan M Sissung; Silja Thordardottir; Erin R Gardner; William D Figg
Journal:  Anticancer Agents Med Chem       Date:  2009-12       Impact factor: 2.505

5.  Interleukin 1β Regulation of the System xc- Substrate-specific Subunit, xCT, in Primary Mouse Astrocytes Involves the RNA-binding Protein HuR.

Authors:  Jingxue Shi; Yan He; Sandra J Hewett; James A Hewett
Journal:  J Biol Chem       Date:  2015-11-24       Impact factor: 5.157

6.  p38 Mitogen-activated protein kinase- and HuR-dependent stabilization of p21(Cip1) mRNA mediates the G(1)/S checkpoint.

Authors:  Vanesa Lafarga; Ana Cuadrado; Isabel Lopez de Silanes; Rocio Bengoechea; Oscar Fernandez-Capetillo; Angel R Nebreda
Journal:  Mol Cell Biol       Date:  2009-06-15       Impact factor: 4.272

7.  Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping.

Authors:  David C Johnson; Sophie Corthals; Christine Ramos; Antje Hoering; Kim Cocks; Nicholas J Dickens; Jeff Haessler; Harmut Goldschmidt; J Anthony Child; Sue E Bell; Graham Jackson; Dalsu Baris; S Vincent Rajkumar; Faith E Davies; Brian G M Durie; John Crowley; Pieter Sonneveld; Brian Van Ness; Gareth J Morgan
Journal:  Blood       Date:  2008-09-19       Impact factor: 22.113

8.  Discovering and validating unknown phospho-sites from p38 and HuR protein kinases in vitro by Phosphoproteomic and Bioinformatic tools.

Authors:  Elena López; Isabel López; Julia Sequí; Antonio Ferreira
Journal:  J Clin Bioinforma       Date:  2011-07-06

9.  TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation.

Authors:  Karim Belarbi; Timothy Jopson; David Tweedie; Carla Arellano; Weiming Luo; Nigel H Greig; Susanna Rosi
Journal:  J Neuroinflammation       Date:  2012-01-25       Impact factor: 8.322

10.  Therapeutic effect of the immunomodulatory drug lenalidomide, but not pomalidomide, in experimental models of rheumatoid arthritis and inflammatory bowel disease.

Authors:  Belen Lopez-Millan; Rafael Diaz de la Guardia; Heleia Roca-Ho; Carmen M García-Herrero; Jessie R Lavoie; Michael Rosu-Myles; Elena Gonzalez-Rey; Francisco O'Valle; Gabriel Criado; Mario Delgado; Pablo Menendez
Journal:  Exp Mol Med       Date:  2017-02-03       Impact factor: 8.718

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.